3 Takeaways From FDA Cell And Gene Therapy Draft Guidance
On Sept. 25, the U.S. Food and Drug Administration published three draft guidance documents that sketch the clearest picture yet of the evolving regulatory framework for cell and gene therapies, or...To view the full article, register now.
Already a subscriber? Click here to view full article